CHS Inc.

CHSCL

NASDAQ · Farm Products & Agribusiness

$24.32

At close - Nov 6, 4:00 PM EST - USD

Market Cap$298M

P/E-

52W High$25.95

Volume48.35K

VCP Research Verdict2026Q2

Cyclical Commodity Headwinds Pressure Operational Profitability Metrics

CHS Inc. faces significant structural challenges as revenue contraction and razor-thin gross margins of 0.3% in 2026Q2 highlight the volatility inherent in its agricultural and energy segments.

GrowthContracting

ProfitabilityStrained

ValuationAttractive

TechnicalsWeak

Explore valuation models

MARKET ACTION

CHSCL price & volume

Price trend, volume and key moving averages

Launch Terminal

Loading chart...

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return

CHSCL+1.20%

S&P 500 (^GSPC)+7.63%

1-Year Return

CHSCL+2.44%

S&P 500 (^GSPC)+9.69%

3-Year Return

CHSCL+18.13%

S&P 500 (^GSPC)+68.81%

5-Year Return

CHSCL+15.31%

S&P 500 (^GSPC)+56.85%

Growth & profitability

Annual revenue & EPS trend

Revenue FY26

$39.23B+10.6% YoY

Net income FY26

$1.1B+83.3% YoY

Free cash flow FY26

$1.58B+535.0% YoY

Operating margin FY26

1.5%+1.2 pts YoY

ROIC (FY26)3%

Avg ROIC 5Y5.9%

ROE (TTM)9.7%

Piotroski Score9 / 9

Financial Statements →

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History

Quarter	EPS (Act vs Est)	Revenue (Act vs Est)
Q3 2026Latest Jul 8, 2026	— vs —	$11.6B vs —

Historical baseline: 1 quarters analyzedGAAP / Adjusted

MARKET COVERAGE

Latest News

2 Stories

Newsfile Corp·Oct 13, 2026

Comprehensive Healthcare Systems to Acquire Third Party Administrator (TPA) America's Choice Healthplans, Moving from Benefits Software to Benefits Outcomes

The combination pairs CHS's Novus360 software platform & system of record with an established U.S. third-party administrator to create one integrated technology and solution platform. It expands CHS into technology-enabled benefits administration and is the first step in a potential roll-up of the fragmented U.S. TPA market.

Defense World·Sep 17, 2026

CHS (NASDAQ:CHSCL) Stock Price Crosses Below 50 Day Moving Average – Should You Sell?

CHS Inc. (NASDAQ: CHSCL - Get Free Report) shares crossed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $25.38 and traded as low as $25.00. CHS shares last traded at $25.07, with a volume of 46,053 shares trading hands. CHS Price Performance The company's fifty day

Filtered for CHS Inc.More Headlines

Compare before deciding

Benchmark CHSCL against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for CHS Inc. (CHSCL)

Full Screener →

Company	Price	Market Cap	P/E Ratio	Rev Growth (1Y)	Net Margin	ROE	Div Yield
CHSCLCHS Inc.Current	$24.32	$298.46M	—	10.63%	2.79%	9.72%	—
ADMArcher-Daniels-Midland Company	$69.97	$33.72B	13.64	-6.15%	2.95%	10.55%	2.91%
BGBunge Global S.A.	$99.10	$19.04B	16.59	32.43%	1.24%	6.61%	2.78%
INGRIngredion Incorporated	$91.72	$5.78B	10.38	-2.84%	7.83%	12.55%	3.53%
CALMCal-Maine Foods, Inc.	$64.60	$3.03B	51.37	-31.68%	2.32%	2.21%	7.5%
CFCF Industries Holdings, Inc.	$119.39	$18.34B	8.29	19.34%	27.48%	25.78%	1.68%

Compare CHSCL vs Peers

CHS Inc. (CHSCL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ADM

Most directly comparable listed peer for CHSCL.

Scale Benchmark

vs DE

Larger-name benchmark to compare CHSCL against a more recognizable public peer.

Peer Set

Compare Top 5

vs ADM, BG, INGR, CALM

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

CHSCL SEC Filings & Documents

CHS Inc. (CHSCL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 8, 2026·SEC

Material company update

Apr 7, 2026·SEC

Material company update

Apr 3, 2026·SEC

10-K Annual Reports

FY 2025

Nov 5, 2025·SEC

FY 2024

Nov 6, 2024·SEC

10-Q Quarterly Reports

FY 2026

Apr 8, 2026·SEC

FY 2026

Jan 7, 2026·SEC

FY 2025

Jul 9, 2025·SEC

Get notified when CHSCL posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

CHSCL Frequently Asked Questions

CHS Inc. (CHSCL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

What is CHS Inc.'s revenue?

CHS Inc. (CHSCL) reported $39.23B in revenue in fiscal year 2026, which is also its trailing twelve months. That is 96% less than the $1.10T of fiscal year 2002.

How fast is CHS Inc. growing?

CHS Inc. (CHSCL) grew revenue by 10.6% over the trailing twelve months, compared with the twelve months before.

Is CHSCL profitable?

Yes. CHS Inc. (CHSCL) earned $1.10B in net income over the trailing twelve months (a 2.8% net margin).

Dividend & Returns

What is CHSCL's return on equity?

CHS Inc. (CHSCL) had a return on equity (ROE) of 9.7% over the trailing twelve months. That is below the market's typical 10-15%.

What is CHS Inc.'s free cash flow?

CHS Inc. (CHSCL) generated $1.46B in free cash flow over the trailing twelve months.

What if you invested $1,000 in CHSCL back in 2002?

Total return calculator · dividends reinvested · 24+ years of data

See returns →

Quarter

EPS (Act vs Est)

Revenue (Act vs Est)

Q3 2026Latest

Jul 8, 2026

—

vs —

$11.6B

vs —

Company

Price

Market Cap

P/E Ratio

Rev Growth (1Y)

Net Margin

ROE

Div Yield

CHSCLCHS Inc.Current

$24.32

$298.46M

—

10.63%

2.79%

9.72%

—

ADMArcher-Daniels-Midland Company

$69.97

$33.72B

13.64

-6.15%

2.95%

10.55%

2.91%

BGBunge Global S.A.

$99.10

$19.04B

16.59

32.43%

1.24%

6.61%

2.78%

INGRIngredion Incorporated

$91.72

$5.78B

10.38

-2.84%

7.83%

12.55%

3.53%

CALMCal-Maine Foods, Inc.

$64.60

$3.03B

51.37

-31.68%

2.32%

2.21%

7.5%

CFCF Industries Holdings, Inc.

$119.39

$18.34B

8.29

19.34%

27.48%

25.78%

1.68%